United Kingdom Coronary Stent Market Size, Share, and COVID-19 Impact Analysis, By Product type (Drug Eluting Stent, Covered Stent, Bare Metal Stent, Bioresorbable Stent, and Others), By Material Type (Metallic Stent, Cobalt-Chromium, Platinum Chromium, Nickel Titanium, Stainless Steel and others), By Mode of Delivery (Self-expandable and Balloon-expandable), and UK Coronary Stent Market Insights, Industry Trend, Forecasts to 2035

United Kingdom Coronary Stent Market Forecasts to 2035

• The United Kingdom Coronary Stent Market Size Was Estimated at USD 310.1 Million in 2024
• The UK Coronary Stent Size is Expected to Grow at a CAGR of around 2.66% from 2025 to 2035
• The UK Coronary Stent Market Size is Expected to Reach USD 414.1 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The UK Coronary Stent Market Size is anticipated to Reach USD 414.1 Million by 2035, Growing at a CAGR of 2.66% from 2025 to 2035. Rising Prevalence of Cardiovascular Diseases, a strongly developed healthcare system, and technological advancements in the coronary stent market.

Market Overview

The United Kingdom Coronary Stent Market Size refers to manufacturing, distribution, and sale. A stent is a tiny mesh tube that is put into restricted or obstructed coronary arteries to ensure normal blood flow to the heart. They are critical in controlling coronary artery disease (CAD), which is characterised by plaque buildup in the arterial walls. By mechanically supporting the artery and releasing drugs in the case of drug-eluting stents, they prevent restenosis, enhance heart function, and minimize the risk of heart attacks, thus improving patient outcomes and quality of life. The United Kingdom coronary stent market is leading. The United Kingdom has a strong, developed healthcare system, high-profile awareness of cardiovascular disease, and strong reimbursement strategies for interventional cardiology. continued investment in cutting-edge stent technologies, demographic shift toward aging populations, and prevalence of CAD continue to drive market growth and coronary stent therapy innovation. Innovation and improvements in coronary stent are major market trend many firms are creating innovative stent devices, they mainly focus on improvements, including minimizing stent struct thickness, making the stents deliverable in complex vessels, and improving smaller sizes of these stents, this improvement led to increased flexibility, reduced diameters, and greater lengths to handle severe percutaneous coronary interventions (PCIs). Physicians have resorted to coronary stents because of various innovations in the field, like drug-eluting stents, bioresorbable vascular scaffolds, which provide greater effectiveness and safety. Thus, such alterations for enhancing patient satisfaction and removing procedural complexity will benefit market growth. 

Report Coverage

This research report categorizes the market size for the UK coronary stent market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the United Kingdom coronary stent market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the United Kingdom coronary stent market.

Driving Factors

As the population ages and risk factors like obesity and diabetes grow more prevalent, it is expected that the need for coronary stents would increase. The United Kingdom boasts a highly advanced healthcare system due to substantial investments in medical technology. This infrastructure can enable the research and implementation of new medical technologies, such as coronary stents. The regulatory environment in the United Kingdom is advantageous for medical device makers due to the precise standards and legislation in place for their approval and commercialisation. This can assist the sector to flourish while also providing enterprises with direct access to the market.

Restraining Factors

The high costs of stent procedures can restrict adoption and accessibility. Also, alternative options for coronary disease treatments. Safety issues are seen as a big hindrance to the growth of the market, since the issue of safety related to coronary stents compromises patient confidence and restrict their adoption. The regulatory approval process for new stent devices can be rigorous and lengthy. These factors can hamper the UK coronary stent market.

Market Segmentation

The United Kingdom coronary stent market share is classified into product type, material type, and mode of delivery.

• The drug-eluting stent segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom coronary stent market is segmented by product type into drug-eluting stent, covered stent, bare metal stent, bioresorbable stent, and others. Among these, the drug-eluting stent segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. Drug-eluting stent market is driven mainly by the superior clinical outcomes of drug-eluting stents, such as lower rates of restenosis and revascularization as compared to bare-metal stents. Pharmacologically coated drug-eluting stents prevent re-narrowing of arteries after angioplasty, a major milestone in interventional cardiology.

• The metallic stent segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom coronary stent market is segmented by material type into metallic stent, cobalt-chromium, platinum chromium, nickel titanium, stainless steel, and others. Among these, the metallic stent segment held the highest revenue market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The metal stents have durable artery support with decades of open durability of clinically used products, exhibiting a credible record of reliability in both efficacy and safety, at times, which may also prove more cost-effective than others.

• The self-expandable segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The United Kingdom coronary stent market is segmented by mode of delivery into self-expandable and balloon-expandable. Among these, the self-expandable segment held the largest market share in 2024 and is expected to grow at a significant CAGR during the forecast period. The self-expandable stents have greater efficacy; additionally novel self-expandable stent is suitable to treat acute myocardial infarction and trace the enlargement of the artery with perfect accuracy. Such outstanding clinical effectiveness of these stents will influence the segment's growth throughout the forecast period.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the United Kingdom coronary stent market and a with comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Renishaw (UK)
• LivaNova (UK)
• Boston Scientific
• Abbott Laboratories
• GE Healthcare
• Medtronic
• Philips Healthcare
• BIOTRONIC SE
• Others

Market Segment

This study forecasts revenue at the United Kingdom, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the United Kingdom coronary stent market based on the below-mentioned segments:

United Kingdom Coronary Stent Market, By Product Type

• Drug-Eluting Stent
• Covered Stent
• Bare Metal Stent
• Bioresorbable Stent
• Others 

United Kingdom Coronary Stent Market, By Material Type

• Metallic Stent
• Cobalt-Chromium
• Platinum Chromium
• Nickel Titanium
• Stainless Steel
• Others

United Kingdom Coronary Stent Market, By Mode of Delivery

• Self-expandable
• Balloon-expandable